- increased leukocyte cell number / IMPC
- decreased body length / IMPC
- abnormal iris morphology / IMPC
- mydriasis / IMPC
- increased hematocrit / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased erythrocyte cell number / IMPC
- increased lean body mass / IMPC
- improved glucose tolerance / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased hemoglobin content / IMPC
- increased circulating total protein level / IMPC
- decreased total body fat amount / IMPC
C57BL/6N-Fam163atm2b(KOMP)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:14249 |
International strain name | C57BL/6N-Fam163atm2b(KOMP)Wtsi/WtsiOrl |
Alternative name | EPD0830_6_B05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Fam163atm2b(KOMP)Wtsi |
Gene/Transgene symbol | Fam163a |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0830_6_B05. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on KOMP final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased erythrocyte cell number / IMPC
- decreased body length / IMPC
- increased hematocrit / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased leukocyte cell number / IMPC
- increased lean body mass / IMPC
- mydriasis / IMPC
- increased hemoglobin content / IMPC
- improved glucose tolerance / IMPC
- increased circulating total protein level / IMPC
- decreased total body fat amount / IMPC
- abnormal iris morphology / IMPC
- increased circulating alkaline phosphatase level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).